Telsar Pharma
Bridgewater
About Telsar Pharma
Telsar Pharma Inc, a new company that will develop an Astellas drug for a common inflammatory bowel disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $14.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2012)
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/telsar-pharma-2263886 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.